Back to top

Image: Bigstock

FUJIFILM Holdings Corporation

Read MoreHide Full Article

FUJIFILM's expanding product portfolio will boost company’s share in the healthcare market, consequently driving top-line growth. The company has also forged partnerships with the likes of Takeda Pharmaceutical to solidify its position in the healthcare market. Shares have outperformed the industry on a year-to-date basis. However, the company’s choppy Document Solutions business and restructuring expenses remain concern. Moreover, escalating tension over the future of the joint venture with Xerox, post the termination of the merger is likely to drag down shares in the near term.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Fujifilm Holdings Corp. (FUJIY) - free report >>

Published in